Frank Karbe - Sep 15, 2022 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Chief Executive Officer, President, Treasurer and Secretary, Director
Signature
/s/ Mark Heinen, Attorney-in-Fact
Stock symbol
BTTX
Transactions as of
Sep 15, 2022
Transactions value $
$104,695
Form type
4
Date filed
9/15/2022, 08:53 PM
Previous filing
Jul 7, 2022
Next filing
Apr 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $105K +50K $2.09 50K Sep 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.06 to $2.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Remarks:

Chief Executive Officer, President, Treasurer and Secretary